… An Interesting Look at Lobbying Spending on Health Reform from the WSJ Health Blog
This morning’s WSJ notes that drug makers and energy companies spent big on lobbying in the second quarter of this year. That’s logical, given the big push on energy and health-care legislation… so, we took a look at the list of 20 top spenders on lobbying for the first half of 2009 compiled by the Center for Responsive Politics, a nonpartisan group that tracks this sort of thing.
The top spender wasn’t a health-care group, but it’s one that’s been involved in the debate over health reform: The U.S. Chamber of Commerce, which has spent $26.2 million on lobbying so far this year.
Third on the list was PhRMA, the drug industry trade group, which spent $13.1 million. Pfizer was sixth at $11.7 million and Blue Cross/Blue Shield was eighth, at $9.5 million. The ninth-place finisher was another group that isn’t strictly a health-care player, but has been heavily involved in the debate: AARP, which spent $9.4 million.
Hospitals and docs were neck and neck in 12th and 13th place — the American Hospital Association and the American Medical Association spent $8.5 million a piece. The Business Roundtable, another big group that’s been active in the health debate, finished 17th at $7.4 million. And Eli Lilly, which spent $7 million on lobbying, was 18th on the list.